A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors

Molecular Carcinogenesis

Volumn 24, Issue 1, 1999, Pages 47-56

  Haag, Jill D ^a   Brasic, Gerlyn M ^b   Shepel, Laurie A ^a   Newton, Michael A ^c   Grubbs, Clinton J ^d   Lubet, Ronald A ^e   Kelloff, Gary J ^e   Gould, Michael N ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Loss of heterozygosity; Microsatellite instability; Mutation

Indexed keywords

AZOXYMETHANE; DNA; METHYLNITROSOUREA; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

ADENOCARCINOMA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; BREAST TUMOR; COLON TUMOR; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; MALE; MICROSATELLITE INSTABILITY; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PAPILLOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; TRANSITIONAL CELL CARCINOMA;

ALLELES; ANIMALS; AZOXYMETHANE; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; CHROMOSOME MAPPING; CODON; COLONIC NEOPLASMS; FEMALE; GENES, RAS; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MICROSATELLITE REPEATS; POINT MUTATION; RATS; RATS, INBRED F344; RATS, INBRED WF; URINARY BLADDER NEOPLASMS;

EID: 0032931294     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199901)24:1<47::AID-MC7>3.0.CO;2-B     Document Type: Article

References (52)

1. Wiseman RW, Cochran C, Dietrich W, Lander ES, Soderkvist P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci USA 1994;91:3759-3763.
2. Herzog CR, Wang Y, You M. Allelic loss of distal chromosome 4 in mouse lung tumor localize a putative tumor suppressor gene to a region homologous with human chromosome 1 p36. Oncogene 1995;11:1811-1815.
3. Aldaz CM, Liao QY, Paladugu A, Rehm S, Wang H. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: High frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Mol Carcinog 1996;17:126-133.
4. Ritland SR, Rowse GJ, Chang Y, Gendler SJ. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Cancer Res 1997;57:3520-3525.
5. Zhuang SM, Eklund LK, Cochran C, Rao GN, Wiseman RW, Soderkvist P. Allelotype analysis of 2′,3′-dideoxycytidine- and 1,3-butadiene-induced lymphomas m B6C3F1 mice. Cancer Res 1996;56:3338-3343.
6. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/ p16/MTS1 gene is frequently associated with aberrant DNA methylation in ad common human cancers. Cancer Res 1995;55:4525-4530.
7. Geradts J, Wilson PA. High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol 1996;149:15-20.
8. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-639.
9. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 1995;81:957-966, 1995.
10. Olopade OI, Buchhagen DL, Malik K, et al. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 1993;53:2410-2415.
11. Gollahon LS, Chen A, Aldaz CM. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Mol Carcinog 1995;12:7-13.
12. Haag JD, Hsu LC, Newton MA, Gould MN. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Mol Carcinog 1996;17:134-143.
13. Toyota M, Ushijima T, Weisburger JH, et al. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-ammo-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol Carcinog 1996;15:176-182.
14. Canzian F, Ushijima T, Toyota M, Sugimura T, Nagao M. Linkage mapping of the rat Tp53 gene on chromosome 10. Mamm Genome 1996;7:630.
15. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982, pp. 364-401.
16. Kumar R, Barbacid M. Oncogene detection at the single cell level. Oncogene 1988;3:647-651.
17. Newton MA, Gould MN, Reznikoff CA, Haag JD. On the statistical analysis of allelic-loss data. Stat Med 1998;17:1425-1445.
18. Miyasaka K, Ohtake K, Nomura K, et al. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol Carcinog 1995;13:37-43.
19. Davis LM, Caspary WJ, Sakallah SA, et al. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis 1994;15:1637-1645.
20. Lander JK, Fan H. Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice. J Virol 1997;71:3940-3952.
21. Kunz HW, Natori T, Levan G. Report on rat chromosome 1 and 5. Rat Genome 1997;3:15-67.
22. Ding YP, Remmers EF, Du Y, et al. Genetic maps of polymorphic DNA loci on rat chromosome 1. Genomics 1996;36:320-327.
23. Yamada J, Kuramoto T, Serikawa T. A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mamm Genome 1994;5:63-83.
24. Sukumar S, McKenzie K, Chen Y. Animal models for breast cancer. Mutat Res 1995;333:37-44.
25. Cohen MM. Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: Implications for hemihyperplasia, associated neoplasms, and overgrowth. Am J Med Genet 1994;52:233-234.
26. Nakao M, Sasaki H. Genomic imprinting: Significance in development and diseases and the molecular mechanisms. J Biochem 1996;120:467-473.
27. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765-2780.
28. Radford DM, Phillips NJ, Fair KL, Ritter JH, Holt M, Donis-Keller H. Allelic loss and the progression of breast cancer. Cancer Res 1996;56:935-938.
29. Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 1996;56:5260-5265.
30. Saran KK, Gould D, Godec CJ, Verma RS. Genetics of bladder cancer. J Mol Med 1996;74:441-445.
31. Rebbeck TR, Godwin AK, Buetow KH. Variability in loss of constitutional heterozygosity across loci and among individuals: Association with candidate genes in ductal breast carcinoma. Mol Carcinog 1996;17:117-125.
32. Sourvinos G, Kiaris H, Tsikkinis A, Vassilaros S, Spandidos DA. Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumour Biol 1997;18:157-166.
33. Cappellen D, de Medina SGD, Chopin D, Thiery JP, Radvanyi F. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 1997;14:3059-3066.
34. Jiricny J. Mismatch repair and cancer. Cancer Surv 1996;28:47-68.
35. Peltomaki P. DNA mismatch repair gene mutations in human cancer. Environ Health Perspect 1997;105:775-780.
36. Papadopoulos N, Lindblom A. Molecular basis of HNPCC: Mutations of MMR genes. Hum Mutat 1997;10:89-99.
37. Nagao M, Ushijima T, Toyota M, Inoue R, Sugimura T. Genetic changes induced by heterocyclic amines. Mutat Res 1997; 376:161-167.
38. Vani RG, Rao MR. Cloning of the cDNA encoding rat homologue of the mismatch repair gene MSH2 and its expression during spermatogenesis. Gene 1997;185:19-26.
39. Simoneau AR, Spruck III CH, Gonzaiez-Zulueta M, et al. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res 1996;56:5039-5043
40. Aldaz CM, Chen A, Gollahon LS, Russo J, Zappler K. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression. Cancer Res 1992;52:4791-4798.
41. Aldaz CM, Gollahon LS, Chen A. Systematic HRAS amplification in ovary-independent mammary tumors: Correlation with progressively anaplastic phenotypes. Cancer Res 1993;53:5339-5344.
42. Herzog CR, Chen B, Wang Y, Schut HAJ, You M. Loss of heterozygosity on chromosomes 1, 11, 12 and 14 in hybrid mouse lung adenocarcinomas. Mol Carcinog 1996;16:83-90.
43. Kemp CJ, Fee F, Balmain A. Allelotype analysis of mouse skin tumor using polymorphic microsatellites: Sequential genetic alterations on chromosomes 6, 7 and 11. Cancer Res 1993;53: 6022-6027
44. Bremner R, Kemp CJ, Balmain A. Induction of different genetic changes by different classes of chemical carcinogens during progression of mouse skin tumors. Mol Carcinog 1994;11:90-97.
45. Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 1986;46:3958-3963.
46. Hsu LC, Kennan WS, Shepel LA, et al. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res 1994;54:2765-2770.
47. Gould MN. Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. Cancer Res 1994;46:1199-1202
48. Reddy BS, Tokumo K, Kulkarni N, Aligia C, Kelloff G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 1992;13:1019-1023.
49. Singh J, Kelloff G, Reddy BS. Intermediate biomarkers of colon cancer: Modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis. Carcinogenesis 1993;14:699-704.
50. Santos J, Perez de Castro I, Herranz M, Pellicer A, Fernandez-Piqueras J. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in γ-radiation-mduced mouse primary thymic lymphomas. Oncogene 1996;12:669-676.
51. Hegi ME, Devereux TR, Dietrich WF, et al. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 1994;54:6257-6264.
52. Radany EH, Hong K, Kesharvarzi S, Lander ES, Bishop JM. Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4. Proc Natl Acad Sci USA 1997;94:8664-8669.